JP5587215B2 - 併用療法 - Google Patents
併用療法 Download PDFInfo
- Publication number
- JP5587215B2 JP5587215B2 JP2010549109A JP2010549109A JP5587215B2 JP 5587215 B2 JP5587215 B2 JP 5587215B2 JP 2010549109 A JP2010549109 A JP 2010549109A JP 2010549109 A JP2010549109 A JP 2010549109A JP 5587215 B2 JP5587215 B2 JP 5587215B2
- Authority
- JP
- Japan
- Prior art keywords
- zinc
- trimethoprim
- viral
- infection
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0803948.9 | 2008-03-03 | ||
GBGB0803948.9A GB0803948D0 (en) | 2008-03-03 | 2008-03-03 | Combination therapy |
PCT/EP2009/052394 WO2009109531A2 (fr) | 2008-03-03 | 2009-02-27 | Polythérapie |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011513356A JP2011513356A (ja) | 2011-04-28 |
JP2011513356A5 JP2011513356A5 (fr) | 2012-04-12 |
JP5587215B2 true JP5587215B2 (ja) | 2014-09-10 |
Family
ID=39315874
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010549109A Active JP5587215B2 (ja) | 2008-03-03 | 2009-02-27 | 併用療法 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10045984B2 (fr) |
EP (1) | EP2257292B1 (fr) |
JP (1) | JP5587215B2 (fr) |
CN (1) | CN101998856A (fr) |
CA (1) | CA2754281C (fr) |
CY (1) | CY1115555T1 (fr) |
DK (1) | DK2257292T3 (fr) |
ES (1) | ES2507570T3 (fr) |
GB (1) | GB0803948D0 (fr) |
PT (1) | PT2257292E (fr) |
WO (1) | WO2009109531A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2740657C1 (ru) * | 2020-05-15 | 2021-01-19 | Общество С Ограниченной Ответственностью "Промомед Рус" | Противовирусная композиция |
NL2028566B1 (nl) * | 2021-06-29 | 2023-01-09 | Simons Care Innovation Group B V | Een zinkzout huidpleister en werkwijzen |
JP7287730B2 (ja) * | 2021-10-12 | 2023-06-06 | ローバル株式会社 | ウイルスを不活化可能な高濃度亜鉛末塗料 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4125610A (en) * | 1977-07-27 | 1978-11-14 | Bristol-Myers Company | Antibacterial compositions |
US5637311A (en) * | 1995-06-29 | 1997-06-10 | Procyte Corporation | Zinc(II) complexes and methods related thereto |
-
2008
- 2008-03-03 GB GBGB0803948.9A patent/GB0803948D0/en not_active Ceased
-
2009
- 2009-02-27 DK DK09716524.5T patent/DK2257292T3/da active
- 2009-02-27 PT PT97165245T patent/PT2257292E/pt unknown
- 2009-02-27 US US12/920,345 patent/US10045984B2/en active Active
- 2009-02-27 JP JP2010549109A patent/JP5587215B2/ja active Active
- 2009-02-27 CN CN2009801074137A patent/CN101998856A/zh active Pending
- 2009-02-27 EP EP09716524.5A patent/EP2257292B1/fr active Active
- 2009-02-27 WO PCT/EP2009/052394 patent/WO2009109531A2/fr active Application Filing
- 2009-02-27 CA CA2754281A patent/CA2754281C/fr active Active
- 2009-02-27 ES ES09716524.5T patent/ES2507570T3/es active Active
-
2014
- 2014-09-11 CY CY20141100739T patent/CY1115555T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009109531A3 (fr) | 2009-11-12 |
DK2257292T3 (da) | 2014-09-29 |
PT2257292E (pt) | 2014-10-22 |
CN101998856A (zh) | 2011-03-30 |
CA2754281A1 (fr) | 2009-09-11 |
GB0803948D0 (en) | 2008-04-09 |
JP2011513356A (ja) | 2011-04-28 |
ES2507570T3 (es) | 2014-10-15 |
US10045984B2 (en) | 2018-08-14 |
EP2257292B1 (fr) | 2014-07-16 |
CA2754281C (fr) | 2016-12-06 |
CY1115555T1 (el) | 2017-01-04 |
WO2009109531A2 (fr) | 2009-09-11 |
US20110045070A1 (en) | 2011-02-24 |
EP2257292A2 (fr) | 2010-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110325187B (zh) | N-氨基甲酰亚胺基-5-(1-甲基-1h-吡唑-4-基)-2-萘甲酰胺在制备治疗流感的药物中的用途 | |
AU2007345952C1 (en) | Positively charged water-soluble prodrugs of 1H-imidazo[4, 5-c]quinolin-4-amines and related compounds with very high skin penetration rates | |
JP2505944B2 (ja) | (S)―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
EP2983667B1 (fr) | Composés de liaison à nhe3 et procédés d'inhibition du transport de phosphate | |
EP2799071B1 (fr) | Lévocétirizine et montélukast pour le traitement de la grippe et le rhume | |
TW200819430A (en) | Enhanced mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes | |
US9662360B2 (en) | Treatment of herpes, pseudomonas, staph, and hepatitis | |
EP2515889A2 (fr) | Composition antivirale synergique et utilisation associée | |
JP2007291067A (ja) | 医薬組成物 | |
CA2991156A1 (fr) | Compositions et methodes de traitement d'une infection virale | |
JP5587215B2 (ja) | 併用療法 | |
JP2022019937A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物 | |
WO2016120787A1 (fr) | N-acétylcystéine destinée à être administrée par voie orale dans le traitement d'infections des voies respiratoires supérieures et de symptômes associés | |
US20180110774A1 (en) | Compositions and methods for treatment of pulmonary hypertension | |
RU2237475C1 (ru) | Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты) | |
WO2007040188A1 (fr) | Composition médicinale pour inhiber la formation excessive de cellules caliciformes | |
JP2023016055A (ja) | インフルエンザおよび重篤なインフルエンザ状態を有する対象者における、置換された多環性ピリドン誘導体およびそのプロドラッグを使用したインフルエンザの治療 | |
CA3241241A1 (fr) | Association pharmaceutique pour le traitement de l'infection respiratoire causee par le sars-cov-2 | |
WO2015054359A1 (fr) | Procédés et compositions pour le traitement symptomatique du rhume | |
JP2021161105A (ja) | ヒト又は動物の慢性若しくは急性のウイルス感染症及び/又は敗血症の予防若しくは治療のための組成物 | |
JP2008515824A (ja) | 2−イミダゾリン構造を有するα−交感神経興奮薬の新規な使用 | |
JP2006117569A (ja) | ステロイド依存性あるいはステロイド抵抗性潰瘍性大腸炎治療薬 | |
JP5463019B2 (ja) | エピナスチン類とエフェドリン類とを含有する気道杯細胞過形成を抑制するための医薬組成物 | |
TW200838534A (en) | Treatment for irritable bowel syndrome | |
JPS5888311A (ja) | 呼吸器疾患治療剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120224 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120224 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130806 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131106 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20140107 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140407 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140414 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140507 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140514 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140606 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140627 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140723 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5587215 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |